TDM-guided meropenem/vaborbactam-based therapy for successful treatment of intra-abdominal and bloodstream infection caused by KPC-producing ceftazidime/avibactam-resistant Klebsiella pneumoniae in a paediatric liver transplant recipient. [PDF]
Mulé G +8 more
europepmc +1 more source
Classification and applicability of new beta-lactamase inhibitors. [PDF]
Cercenado E, Candel FJ.
europepmc +1 more source
Molecular and pharmacodynamic insights into β-lactam therapy for high-inoculum Enterobacter cloacae complex infections. [PDF]
Kunz Coyne AJ +6 more
europepmc +1 more source
Antimicrobial susceptibility of Enterobacterales causing infection in the elderly: focus on aztreonam-avibactam and recently approved β-lactamase inhibitor combinations. [PDF]
Sader HS +5 more
europepmc +1 more source
Introduction to XIV updating course of antimicrobials and infectious diseases. [PDF]
Candel FJ, Matesanz M.
europepmc +1 more source
β-Lactam/β-Lactamase Inhibitor Combinations in Sepsis-Associated Acute Kidney Injury and Renal Replacement Therapy. [PDF]
Lacquaniti A +10 more
europepmc +1 more source
Significant Prevalence of Dual KPC/NDM Carbapenemase-Producing <i>Klebsiella pneumoniae</i> in an ICU Cohort in Thessaloniki (2023), Including an ST512 Isolate Co-Harboring <i>bla<sub>NDM-1</sub></i> and <i>bla<sub>KPC-3</sub></i>. [PDF]
Chatzidimitriou M +7 more
europepmc +1 more source
Simulated endocardial vegetation model highlights the complexity of high-inoculum infections among β-lactamase-producing organisms. [PDF]
Fratoni AJ.
europepmc +1 more source
Impact of Attaining an Aggressive Pharmacokinetic-Pharmacodynamic Target on the Clinical Efficacy of Continuous Infusion β-Lactam Therapy for Early Posttransplant Gram-Negative Infections in Critically Ill Orthotopic Liver Transplant Recipients: An Interim Analysis of a 3-Year Prospective, Observational Study. [PDF]
Gatti M +10 more
europepmc +1 more source
Structural insights into the activity of carbapenemases: understanding the mechanism of action of current inhibitors and informing the design of new carbapenem adjuvants. [PDF]
Hatzisarantinos T +5 more
europepmc +1 more source

